Further studies are needed to clarify the precise molecular mechanisms by which the TFG regulates thyroid hormone actions and PPARγ activities, specifically in vivo, and its therapeutic potential for preventing steatosis and the associated insulin resistance. The gene discussed is TG; the disease is steatosis.